Bright Uro Announces Award from Congressional Spinal Cord Injury Research Program
$1.75M Grant Awarded to Support Glean Urodynamics System for Bladder Management in
Wounded Veterans
IRVINE, Calif., Jan. 7, 2025 /PRNewswire/ — Bright Uro, a medical device company with a mission to transform care for lower urinary tract symptoms through innovations in urodynamics, today announced a Translational Research Award of $1.75 million from the Spinal Cord Injury Research Program (SCIRP), a Department of Defense Congressionally Directed Medical Research Program1, to support new product development and future innovations of the Glean™ Urodynamics System.
Congress established the SCIRP in 2009 in part as a response to the high rates of spinal cord injury observed in warfighters returning home from duty. Up to 20% of all Americans living with an SCI are combat casualties and the Department of Veterans Affairs operates the largest single SCI care network in the United States2. The SCIRP Congressional program is intended to advance the medical treatment and care management of these wounded warfighters.
More than 300,000 Americans are currently living with an SCI – 79% are male – and about 18,000 new cases are recorded annually3. Neurogenic lower urinary tract dysfunction (nLUTD) affects 80% of SCI patients within the first year after injury and requires daily management of bladder symptoms4. The Glean System’s design enables data-driven bladder management, and this award will aid in the development of a device that will provide patients critical insight of bladder pressures and volumes over an extended period.
“Bright Uro is proud to be recognized by SCIRP as a company deserving of support in our efforts to help wounded veterans with spinal cord injuries,” said Derek Herrera, founder and CEO of Bright Uro and himself a retired Marine Raider who suffered an SCI in combat in Afghanistan. “Safe urinary management is a daily challenge for most paralyzed veterans. We have always believed that Glean could serve as a platform for managing bladder health and be immensely valuable to veterans in need, and to have that belief affirmed by SCIRP is deeply gratifying.”
About Bright Uro
Based in Irvine, Calif., Bright Uro’s mission is to transform the care of LUTD with its innovative technology that is poised to disrupt outdated urodynamics approaches. The Company’s investigational Glean™ Urodynamics System is designed to enable wireless, catheter-free urodynamics monitoring, with the ultimate goal of improving patient comfort and clinical outcomes. For more information, visit www.brighturo.com.
1 | This work was supported by The Assistant Secretary of Defense for Health Affairs endorsed by the Department of Defense, in the amount of $1,749,515 through the Spinal Cord Injury Research Program (SCIRP) under Award Number HT9425-24-1-0675. Opinions, interpretations, conclusions, and recommendations are those of the author(s) and are not necessarily endorsed by The Assistant Secretary of Defense for Health Affairs endorsed by the Department of Defense. |
2 | SCIRP https://cdmrp.health.mil/scirp/ website accessed Dec 31, 2024 |
3 | National Spinal Cord Injury Statistical Center, Traumatic Spinal Cord Injury Facts and Figures. Birmingham, AL: University of Alabama at Birmingham, 2024. |
4 | Biomedicines. 2023 May 26;11(6):1539. doi: 10.3390/biomedicines11061539 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bright-uro-announces-award-from-congressional-spinal-cord-injury-research-program-302344604.html
SOURCE Bright Uro